Generics Cos. Infringed Lysteda IP, Fed. Circ. Told
By Brian Mahoney ( June 10, 2014, 4:57 PM EDT) -- Ferring Pharmaceuticals Inc. asked the Federal Circuit on Tuesday to affirm a finding of infringement against Watson Pharmaceuticals Inc. in a dispute over heavy menstrual bleeding medication Lysteda and to reverse a decision that let Apotex Inc. off the hook for infringing the same drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.